WASHINGTON, April 13, (AP): The US is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to analyze experiences of probably harmful blood clots. In a joint assertion Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration stated they had been investigating uncommon clots in six ladies that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the mind and occurred along with low platelets.
All six circumstances had been in ladies between the ages of 18 and 48. The experiences seem much like a uncommon, uncommon sort of clotting dysfunction that European authorities say is presumably linked to a different COVID-19 vaccine not but cleared within the US, from AstraZeneca. More than 6.8 million doses of the J&J vaccine have been administered within the US, the overwhelming majority with no or gentle unintended effects. US federal distribution channels, together with mass vaccination websites, will pause the usage of the J&J shot, and states and different suppliers are anticipated to comply with.
The different two approved vaccines, from Moderna and Pfizer, make up the huge share of COVID-19 photographs administered within the US and aren’t affected by the pause. CDC’s Advisory Committee on Immunization Practices will meet Wednesday to debate the circumstances and the FDA has additionally launched an investigation into the reason for the clots and low platelet counts. “Until that course of is full, we’re recommending a pause in the usage of this vaccine out of an abundance of warning,” Dr. Anne Schuchat, principal deputy director of the CDC, and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, stated in a joint assertion.
The put up US urges ‘pause’ for J&J vaccine on clot experiences – Six ladies affected appeared first on ARAB TIMES – KUWAIT NEWS.